Personalised medicine based on the genetics of each person.
The EuroEspes Health Genetic Screening consists of several tests that can be performed at home with a simple saliva sample. We take care of shipping and collection for your convenience.
The main tests are:
Risk Genetics in relation to Alzheimer's, Parkinson's, neuropsychiatric diseases, alcoholism, cardiovascular diseases, hypertension, metabolic syndrome, nutrition, etc.
Pharmacogenetics linked to general and specific treatments for certain pathologies (anticoagulants, anti-inflammatory drugs, analgesics, antidepressants, anaesthetics, antipsychotics, anxiolytics, antiepileptics, etc.).
1.- Risk genetics
Prevention is the best strategy for a healthier life. Today, thanks to genome sequencing, it is possible to know an individual's predisposition to disease several years in advance by identifying genetic risks and monitoring biomarkers.
What is genetic risk?
It is defined as the presence of certain variations in the DNA sequence and/or the combination of a series of them in an individual. These variations are not necessarily abnormal, but an increased risk of developing a certain disease can be associated with them.
Most of the diseases of adult life (diabetes, hypertension, hyperlipidaemia, osteoporosis, heart disease, cancer, dementia, stroke, etc.) fall under the concept of polygenic diseases, characterised by multiple genetic defects in different regions of the human genome, which, given certain environmental and lifestyle conditions, make us more susceptible to disease.
Early identification of the risk of developing a certain disease allows for personalised prevention strategies to be designed to avoid its clinical onset or reduce its associated complications. Euroespes Health has several panels to assess the genetic risk associated with different pathologies.
The ability of an individual to properly metabolise the active ingredients of each pharmaceutical product depends on their genetic profile.
The combination of Pharmacology and Genetics results in what is defined as Pharmacogenetics, which is the discipline that deals with the study of hereditary variations that affect individual response to drugs.
Each person metabolises drugs differently, therefore, in many cases, doses are prescribed that are ineffective or even worse: they cause adverse effects (toxicity). This is due to the genetic basis related to the proteins (enzymes) responsible for the transport and metabolism of these drugs. Each person possesses a series of variations in the code of these genes, which means that they have a personalised tolerance profile for certain drugs.
Adverse drug events are one of the leading causes of hospitalisation and death in the world.
Therefore, the study of the genes involved in the metabolism of drugs is essential for the personalisation of the prescription of medicines, and for adapting them to the characteristics of each person and as a result avoiding the use of drugs with:
Risky interactions (when more than one medicine is taken at the same time, the combination may increase the potential for toxicity)
Euroespes Health is an international pioneer in the development of pharmacogenetic analysis tools.